Epidemiology of end-stage renal disease

Clinical Medicine

Volumn 2, Issue 3, 2002, Pages 200-204

  Roderick, Paul ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; SEX RATIO; TIME; UNITED KINGDOM;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; GREAT BRITAIN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION; TIME FACTORS;

EID: 0036560806     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.2-3-200     Document Type: Article

References (43)

1. Cockcroft D, Gault MK. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
2. Mallick NP. The costs of renal services in Britain. Review. Nephrol Dial Transplant 1997;12(Suppl 1):25-8.
3. Kissmeyer L, Kong C, Cohen J, Unwin RJ, et al. Community nephrology: audit of screening for renal insufficiency in a high risk population. Nephrol Dial Transplant 1999;14:2150-5.
4. Jungers P, Chauveau P, Descamps-Latscha B, Labrunie M, et al. Age and gender-related incidence of chronic renal failure in a French urban area: a prospective epidemiologic study. Nephrol Dial Transplant 1996; 11:1542-6.
5. Goldacre MJ. Cause-specific mortality: understanding uncertain tips of the disease iceberg. J Epidemiol Community Health 1993;47:491-6.
6. Drey N. The epidemiology of diagnosed chronic renal failure in Southampton in South West Hampshire Health Authority. University of Southampton, PhD thesis, 2000.
7. Khan IH, Catto GR, Edward N, MacLeod AM. Chronic renal failure; factors influencing nephrology referral. QJM 1994;87: 559-64.
8. Feest TG, Mistry CD, Grimes DS, Mallick NP. Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment. Br Med J 1990;301: 987-90.
9. Culleton BF, Larson MG, Evans JC, Wilson PW, et al. Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. Arch Intern Med 1999;159:1785-90.
10. Gregory J, Foster K, Tyler H, Wiseman M. The dietary and nutritional survey of british adults. London: HMSO, 1990.
11. Finch S, Doyle W, Lowe C, Bates CJ, et al. National diet and nutrition survey: people aged 65 years and over. London: HMSO, 1998.
12. United States Renal Data System. 1999 Annual Data Report. US Department of Health & Human Services, Public Health Service, National Institutes of Health. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Disease, 1999.
13. Roderick PJ, Jones I, Raleigh VS, McGeown MG, Mallick NP. Population need for renal replacement therapy in the Thames regions: ethnic dimension. Br Med J 1994;309: 1111-4.
14. Roderick PJ, Raleigh VS, Hallam L, Mallick NP. The need and demand for renal replacement therapy in ethnic minorities in England. J Epidemiol Community Health 1996;50:334-9.
15. Balarajan R, Bulusu L. Mortality among migrants in England and Wales, 1978-83. In: Britten M (ed). Mortality and geography: a review in the mid-1980s, England and Wales. Office of Population Censuses and Surveys, Series DS no. 9. London: Her Majesty's Stationery Office, 1990:103-21.
16. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-6.
17. Raleigh V. Diabetes and hypertension in Britain's ethnic minorities: implications for the future of renal services. Review. Br Med J 1997;314:209-13.
18. Mather HM, Chaturvedi N, Kehely AM. Comparison of prevalence and risk factors for microalbuminuria in South Asians and Europeans with type 2 diabetes mellitus. Diabet Med 1998;15:672-7.
19. Earle KK, Porter KA, Ostberg J, Yudkin JS. Variation in the progression of diabetic nephropathy according to racial origin. Nephrol Dial Transplant 2001;16:286-90.
20. Lightstone L. Preventing kidney disease: the ethnic challenge. Peterborough: National Kidney Research Fund, 2001.
21. Occupational health decennial supplement No. 10, 1995. London: Office for National Statistics, 1995.
22. Marmot MG, Smith GD, Stansfeld S, Patel C, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet 1991;337:1387-93.
23. Boyle PJ, Kudlac H, Williams AJ. Geographical variation in the referral of patients with chronic end stage renal failure for renal replacement therapy. QJM 1996; 89:151-7.
24. Roderick P, Clements S, Stone N, Martin D, Diamond I. What determines geographical variation in rates of acceptance onto renal replacement therapy in England? J Health Serv Res Policy 1999;4:139-46.
25. Khan IN, Cheng J, Catto GR, Edward N, MacLeod AM. Social deprivation indices of patients on renal replacement therapy (RRT) in Grampian. Scott Med J 1993;38: 139-41.
26. Metcalfe W, MacLeod AM, Bennett D, Simpson K, Khan IH. Equity of renal replacement therapy utilization: a prospective population-based study. QJM 1999;92:637-42.
27. UK Renal Registry. Third Annual Report. Bristol: Renal Registry, 2000. www.renalreg.com
28. Frassinetti Fernandes P, Ellis PA, Roderick PJ, Cairns HS, et al. Causes of end-stage renal failure in black patients starting renal replacement therapy. Am J Kidney Dis 2000;36:301-9.
29. Fogo A, Breyer JA, Smith MC, Cleveland WH, et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. Kidney Int 1997;51:244-52.
30. Feest T, Rajamahesh J, Taylor H, Roderick P. The provision of renal replacement therapy for adults in the UK 1998. Report for Department of Health, September 2000. (Included as Chapter 3 in Ref 26.)
31. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14(Suppl 5):S1-85.
32. Government Actuary's Office. National population projections 1994 based. Series PP2 No 20. London: Office for National Statistics, 1996.
33. Lamping DL, Constantinovici N, Roderick P, Normand C, et al. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study. Lancet 2000;356:1543-50.
34. Valderrabano F, Berthoux FC, Jones EH, Mehls O. Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The European Dialysis and Transplant Association-European Renal Association Registry. Review. Nephrol Dial Transplant 1996; 11(Suppl 1):2-21.
35. Eadington DW. Delayed referral for dialysis. Review. Nephrol Dial Transplant 1996;11: 2124-6.
36. Ellis PA, Reddy V, Bari N, Cairns HS. Late referral of end-stage renal failure. QJM 1998;91:727-32.
37. Roderick P, Jones C, Tomson C, Mason J. Is late referral for renal replacement therapy avoidable? J Am Soc Nephrol 2001;12:241A.
38. Scottish Renal Registry. Second Annual Report. Edinburgh: Information Statistics Division, 2001. www.show.scot.nhs.uk/srr
39. Khan IH, Catto GR, Edward N, Fleming LW, et al. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993;341:415-8.
40. Chandna SM, Schulz J, Lawrence C, Greenwood R, Farrington K. Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. Br Med J 1999;318: 217-23.
41. Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Review. Lancet 2000;356: 147-52.
42. Roderick P, Clements S, Diamond, Storkey M, Raleigh V S. Estimating demand for renal replacement therapy in Greater London: the impact of demographic trends in ethnic minority populations. Health Trends 1998;30:46-50.
43. Davies RM, Roderick P. Predicting the future demand for renal replacement therapy in England using simulation modelling. Nephrol Dial Transplant 1997;12: 2512-6.